Coronavirus Update: How Should Remdesivir Be Priced? ICER Are In Two Minds
Plus Moderna and Daiichi Sankyo Updates
• By Scrip Team
Gilead will be heartened by the 'cost recovery' model, but new dexamethasone data is likely to have the biggest impact. 
